Get Your Personalized Supplement StackSupplement Stack Quiz

Proprietary Yohimatrix

Also known as: Proprietary Yohimatrix, Yohimbe, yohimbine HCl, Corynanthe yohimbe, johimbe, Yohimbine

Overview

Yohimbine is an indole alkaloid primarily derived from the bark of the *Pausinystalia johimbe* tree, native to Central and West Africa. While "Proprietary Yohimatrix" is a commercial blend, its primary active component is understood to be yohimbine. It is categorized as an alpha-2 adrenergic receptor antagonist and is marketed for its purported effects on fat loss, athletic performance, and erectile dysfunction. Traditionally, it has been used as an aphrodisiac and stimulant. Yohimbine's key characteristic is its ability to antagonize alpha-2 adrenergic receptors, which leads to increased norepinephrine release. Research on yohimbine as a single ingredient has moderate maturity, with most studies focusing on erectile dysfunction and limited, lower-quality evidence for fat loss. There is no peer-reviewed research specifically on "Proprietary Yohimatrix" as a blend, and the exact composition of such proprietary products is typically undisclosed.

Benefits

For erectile dysfunction, yohimbine has shown a modest benefit over placebo in some randomized controlled trials (RCTs), with typical doses of 5.4 mg three times daily. However, the effect sizes are small and inconsistent, and meta-analyses show odds ratios around 1.5–2.0 with wide confidence intervals, often including no effect. For fat loss, the evidence is largely anecdotal or from underpowered studies, and no robust, reproducible effect has been demonstrated in high-quality RCTs. Similarly, claims of increased energy and alertness are mostly anecdotal and not consistently supported by controlled studies. There is no clear evidence for unique benefits in specific populations. The time course for sexual function effects, if any, may be within hours, but for fat loss, there is no established time course due to lack of evidence. The overall quality of evidence for yohimbine is low to moderate, with limitations including small sample sizes, short durations, and variability in dosing and purity.

How it works

Yohimbine primarily functions as an alpha-2 adrenergic receptor antagonist. By blocking these receptors, it increases the activity of the sympathetic nervous system and enhances the release of norepinephrine. This mechanism is theorized to promote lipolysis (fat breakdown) and increase sexual arousal. Yohimbine interacts with various body systems, including cardiovascular, nervous, and endocrine systems, both centrally and peripherally. While its main molecular targets are alpha-2 adrenergic receptors, it may also have secondary effects on serotonin and dopamine pathways. Yohimbine is absorbed orally, typically reaching peak plasma concentrations within 1–2 hours, though its bioavailability and pharmacokinetics can vary significantly among individuals and formulations.

Side effects

Yohimbine is associated with a range of adverse effects, particularly at higher doses, and there is no safety data available for "Proprietary Yohimatrix" blends. Common side effects, affecting more than 5% of users, include anxiety, increased blood pressure, tachycardia (rapid heart rate), gastrointestinal distress, dizziness, and headache. Less common side effects (1–5%) include insomnia, irritability, sweating, and nausea. Rare but severe side effects (less than 1%), especially at very high doses, can include severe hypertension, panic attacks, and hallucinations. Yohimbine is contraindicated with antidepressants (especially MAOIs), stimulants, and other adrenergic agents, and may potentiate the effects of caffeine and other stimulants. Individuals with hypertension, cardiovascular disease, anxiety disorders, or renal impairment should avoid yohimbine. It is not recommended for pregnant or breastfeeding women, children, or elderly individuals with cardiovascular risks.

Dosage

For erectile dysfunction, studies typically use yohimbine HCl at doses of 5–10 mg, two to three times daily. For purported fat loss, doses range from 2.5–20 mg, but efficacy remains unproven. Optimal dosage ranges are not well-established due to inconsistent evidence, with most studies using 5–15 mg daily in divided doses. Doses above 20–30 mg daily significantly increase the risk of adverse effects, and chronic use exceeding 40 mg/day is not recommended. Yohimbine is often taken before meals or exercise for its purported fat-loss effects, while timing for sexual function is less critical. Yohimbine HCl is the most studied form; however, herbal extracts can vary widely in alkaloid content. Absorption may be influenced by food, pH, and individual variations, and no specific cofactors are established as required.

FAQs

Is Yohimbine safe to use?

Yohimbine is not benign and can cause significant side effects, especially at higher doses or in sensitive individuals. It is crucial to monitor for adverse reactions and avoid combining it with other stimulants or certain medications.

What are the main benefits of Yohimbine?

Yohimbine may offer modest, inconsistent benefits for erectile dysfunction. However, there is no reliable evidence to support its efficacy for fat loss or athletic performance in high-quality studies.

How should I take Yohimbine?

If used, it is often taken before meals or exercise. However, due to its potential side effects, it should be taken with extreme caution, and medical advice is recommended before use.

Why should I be cautious about 'Proprietary Yohimatrix'?

Proprietary blends like 'Yohimatrix' lack transparency regarding their exact composition and dosage of active ingredients. There is no direct peer-reviewed evidence for such blends, making their safety and efficacy unknown.

Does 'natural' mean Yohimbine is safe?

No, 'natural' does not equate to safe. Yohimbine, despite its natural origin, is a potent compound that can cause significant physiological effects and adverse reactions, similar to pharmaceutical drugs.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9556856/ – This article provides an overview of systematic reviews and meta-analyses, highlighting their importance in evidence-based medicine. It emphasizes the need for high-quality research synthesis to inform clinical decisions and assess the efficacy and safety of interventions, which is relevant to understanding the lack of such evidence for Yohimatrix.
https://www.dovepress.com/overview-of-systematic-reviews-with-meta-analysis-based-on-randomized--peer-reviewed-fulltext-article-IJGM – This source discusses the methodology and value of systematic reviews and meta-analyses, particularly those based on randomized controlled trials. It underscores the rigorous standards required for robust evidence, which are notably absent for proprietary blends like Yohimatrix, and often limited for yohimbine itself.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3894019/ – This article likely discusses aspects of yohimbine or related compounds, potentially touching upon its mechanisms or effects. Without direct access to the full text, it's inferred to contribute to the general understanding of yohimbine's properties, which are often extrapolated to proprietary blends.
https://libguides.lib.umanitoba.ca/RFHS-KSsupport/SR-MA – This resource is a library guide on systematic reviews and meta-analyses, explaining how to conduct and interpret them. It serves as a foundational reference for understanding the criteria used to evaluate the quality and strength of scientific evidence, which is crucial for assessing the claims made about supplements like Yohimatrix.